253 related articles for article (PubMed ID: 17244360)
41. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
42. New frontiers in biomarkers for hepatocellular carcinoma.
Giannelli G; Antonaci S
Dig Liver Dis; 2006 Nov; 38(11):854-9. PubMed ID: 16782417
[TBL] [Abstract][Full Text] [Related]
43. [Therapeutic advances in hepatocellular carcinoma].
Poupon R; Fartoux L; Rosmorduc O
Bull Acad Natl Med; 2008 Jan; 192(1):23-31; discussion 31-2. PubMed ID: 18663979
[TBL] [Abstract][Full Text] [Related]
44. Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma.
Zhang JY
Autoimmun Rev; 2007 Jan; 6(3):143-8. PubMed ID: 17289549
[TBL] [Abstract][Full Text] [Related]
45. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
46. Serum markers of hepatocellular carcinoma.
Spangenberg HC; Thimme R; Blum HE
Semin Liver Dis; 2006 Nov; 26(4):385-90. PubMed ID: 17051452
[TBL] [Abstract][Full Text] [Related]
47. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
Hussain K; El-Serag HB
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
[TBL] [Abstract][Full Text] [Related]
48. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics.
Yang N; Ekanem NR; Sakyi CA; Ray SD
Adv Drug Deliv Rev; 2015 Jan; 81():62-74. PubMed ID: 25450260
[TBL] [Abstract][Full Text] [Related]
49. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE
Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380
[TBL] [Abstract][Full Text] [Related]
50. New possibilities in hepatocellular carcinoma treatment.
Rasool M; Rashid S; Arooj M; Ansari SA; Khan KM; Malik A; Naseer MI; Zahid S; Manan A; Asif M; Razzaq Z; Ashraf S; Qazi MH; Iqbal Z; Gan SH; Kamal MA; Sheikh IA
Anticancer Res; 2014 Apr; 34(4):1563-71. PubMed ID: 24692683
[TBL] [Abstract][Full Text] [Related]
51. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma.
Hayashi PH; Di Bisceglie AM
Med Clin North Am; 2005 Mar; 89(2):345-69. PubMed ID: 15656930
[TBL] [Abstract][Full Text] [Related]
52. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
Song W; Li H; Tao K; Li R; Song Z; Zhao Q; Zhang F; Dou K
Int J Clin Pract; 2008 Aug; 62(8):1212-8. PubMed ID: 18479363
[TBL] [Abstract][Full Text] [Related]
53. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
Peng XQ; Wang F; Geng X; Zhang WM
Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
[TBL] [Abstract][Full Text] [Related]
54. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
Cai MY; Tong ZT; Zheng F; Liao YJ; Wang Y; Rao HL; Chen YC; Wu QL; Liu YH; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
Gut; 2011 Jul; 60(7):967-76. PubMed ID: 21330577
[TBL] [Abstract][Full Text] [Related]
55. Metastatic hepatocellular carcinoma to the skin staining positive with HMB-45.
Gross JA; Perniciaro C; Gross DJ; Barksdale SK
Am J Dermatopathol; 2012 Feb; 34(1):110-2. PubMed ID: 22262362
[TBL] [Abstract][Full Text] [Related]
56. Advances in liver fibrosis imaging and hepatocellular carcinoma: update in 2013. Preface.
Kudo M
Oncology; 2013; 84 Suppl 1():1-2. PubMed ID: 23428851
[No Abstract] [Full Text] [Related]
57. Hepatocellular carcinoma: diagnostics and screening.
Patel M; Shariff MI; Ladep NG; Thillainayagam AV; Thomas HC; Khan SA; Taylor-Robinson SD
J Eval Clin Pract; 2012 Apr; 18(2):335-42. PubMed ID: 21114800
[TBL] [Abstract][Full Text] [Related]
58. [The role of tumor markers in the diagnosis and follow-up of liver tumors].
Ottó S
Orv Hetil; 2004 Feb; 145(7 Suppl 1):385-7. PubMed ID: 15049057
[TBL] [Abstract][Full Text] [Related]
59. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Li J; Wei L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
[TBL] [Abstract][Full Text] [Related]
60. RNA interference against cancer/testis genes identifies dual specificity phosphatase 21 as a potential therapeutic target in human hepatocellular carcinoma.
Deng Q; Li KY; Chen H; Dai JH; Zhai YY; Wang Q; Li N; Wang YP; Han ZG
Hepatology; 2014 Feb; 59(2):518-30. PubMed ID: 23929653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
